Cherry Dental Financing: What Practices Need to Know

Cherry dental financing is a third-party patient financing platform that lets dental practices offer monthly payment plans at the point of care — without building their own lending program or taking on compliance overhead. It’s aimed squarely at practices that want to reduce the “I need to think about it” response when presenting a treatment plan.

One quick clarification before going further: Cherry the financing platform is entirely unrelated to Cherry Tree Dental, the Wisconsin-based DSO recently acquired by Delta Dental of Wisconsin. Same first word, completely different businesses. The rest of this article is about the financing platform only.

How Cherry Dental Financing Works

The patient-facing side is deliberately simple. A patient fills out an application on their phone in about 35 seconds. There’s no hard credit check and no deferred interest — two friction points that make patients wary of traditional medical credit products. Once approved, the practice gets paid for the treatment and Cherry handles the installment relationship with the patient.

That structure matters for practices. You’re not waiting on the patient to pay off a balance or chasing collections — the third-party model shifts that risk. Per the ADA’s guidance on patient financing options, one of the primary advantages of working with an external lender is exactly this: the lender, not the practice, manages compliance with state and federal lending regulations.

Approval Rates and Fees

Cherry claims approval rates as high as 90% and positions its fees as the lowest in the industry — both vendor-reported figures, so take them as directional rather than independently audited benchmarks. The company also says providers choose Cherry five times more often than competitors when selecting a preferred financing partner, and that more than 50,000 providers currently use the platform. Again, those numbers come from Cherry’s own marketing materials, but the scale suggests the platform has meaningful traction.

What independent context can tell us: ADA Health Policy Institute data shows that dentist confidence in their own practices hit an all-time low in Q1 2025, down sharply from Q4 2024. When practitioners are pessimistic about production, tools that help convert scheduled treatment into accepted treatment get a harder look.

The Case for Third-Party Financing (and Its Limits)

The core argument is case acceptance. Patients who don’t have the cash on hand for a crown, implant, or orthodontic case often postpone — or simply decline — care. Knowing a manageable monthly payment exists at the point of consultation shortens that decision window. Dental Economics has noted that financing conversations, when handled well, can meaningfully reduce the time between diagnosis and scheduling.

That said, third-party financing isn’t free. Processing fees vary by platform and plan, and practices need to model whether increased case volume offsets what they give up per transaction. Cherry positions its fees as competitive, but you should get a clear rate sheet and run the math for your case mix — a high-volume general practice has a different calculus than a specialty office presenting fewer, larger cases.

There’s also the patient experience angle. No deferred interest is genuinely meaningful. The backlash against traditional healthcare credit products with retroactive interest charges is well-documented; patients who feel burned by financing terms don’t come back.

Platform Integration: Cherry and Clerri

In June 2026, Clerri — described as the dental industry’s largest membership platform — announced a native integration with Cherry. Front-office staff can now initiate a Cherry financing pre-approval directly from the patient’s treatment plan view inside Clerri, without switching to a separate application or tab.

Setup for practices already on Clerri is a three-step process: navigate to Product Settings, select Connect Cherry in the Clerri Practice Portal, and paste an API key. According to Clerri, the whole thing takes about two minutes. Practices new to Cherry complete a one-time approval as part of that setup.

This kind of embedded workflow is worth paying attention to. The more steps a front-desk team has to take — logging into a separate portal, re-entering patient data — the less consistently financing gets offered. Reducing that friction at the staff level is probably more valuable than any marginal difference in approval rates between platforms.

For practices evaluating broader practice software options, workflow integration should be near the top of the checklist. If your practice management system or membership platform can surface financing options within the treatment planning workflow, you’re far more likely to see consistent adoption. It’s worth reviewing how your current setup compares to the best dental practice management software on the market before committing to any financing integration.

Who Cherry Makes Sense For

Cherry looks like a reasonable fit for practices that present a lot of elective or cosmetic treatment, run a membership or in-house discount plan (especially now that Clerri integration is live), or are currently losing cases to sticker shock without a clear financing pathway in place.

It’s less obviously necessary for practices where most treatment is insurance-covered and high-dollar elective cases are rare. And it’s worth comparing against competitors — CareCredit and Lending Club Patient Solutions are the two most common alternatives — on fee structure and approval criteria for your specific patient demographic before signing up.

The no-hard-credit-check application is a genuine differentiator for practices serving patients with thin or imperfect credit histories. That alone can shift who says yes.